Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | May 22, 2024 | 12.57 | -2.78 |
Oak Valley Bancorp | OVLY | May 22, 2024 | 24.28 | +0.75 |
Oak Woods Acquisition | OAKU | May 22, 2024 | 10.79 | +0.09 |
Oaktree Capital A Pref | OAK-A | May 22, 2024 | 22.24 | -0.54 |
Oaktree Capital Group B Pref | OAK-B | May 22, 2024 | 21.77 | -0.23 |
Oaktree Specialty | OCSL | May 22, 2024 | 19.05 | -0.88 |
Oatly ADR | OTLY | May 22, 2024 | 1.16 | -0.85 |
Oblong | OBLG | May 22, 2024 | 0.19 | +15.26 |
OCA Acquisition A | OCAX | May 22, 2024 | 10.96 | 0.00 |
Occidental Petroleum | OXY | May 22, 2024 | 62.66 | -1.09 |
Ocean Biomedical | OCEA | May 22, 2024 | 1.55 | -4.62 |
Ocean Power Technologies | OPTT | May 22, 2024 | 0.19 | +1.68 |
Oceaneering International | OII | May 22, 2024 | 23.18 | -4.53 |
OceanFirst Financial | OCFC | May 22, 2024 | 15.62 | -1.26 |
OceanFirst Pref | OCFCP | May 22, 2024 | 24.46 | -0.69 |
OceanPal | OP | May 22, 2024 | 2.45 | -2.17 |
Ocugen | OCGN | May 22, 2024 | 1.72 | -7.03 |
Ocular Therapeutix | OCUL | May 22, 2024 | 6.00 | -1.64 |
Oculis | OCS | May 22, 2024 | 11.90 | 0.00 |
Ocuphire Pharma | OCUP | May 22, 2024 | 1.77 | +2.31 |
Ocwen Financial | OCN | May 22, 2024 | 25.50 | +1.47 |
Oddity Tech | ODD | May 22, 2024 | 37.27 | -1.83 |
Odyssey Marine Exploration | OMEX | May 22, 2024 | 4.01 | +1.52 |
Offerpad Solutions A | OPAD | May 22, 2024 | 4.90 | -10.58 |
Office Properties | OPI | May 22, 2024 | 2.29 | -1.72 |
OFG Bancorp | OFG | May 22, 2024 | 37.11 | -0.72 |
OFS Capital | OFS | May 22, 2024 | 9.71 | -1.87 |
OFS Credit | OCCI | May 22, 2024 | 7.46 | +0.81 |
OFS Credit C Pref | OCCIO | May 22, 2024 | 24.01 | -0.87 |
OFS Credit E Pref | OCCIN | May 22, 2024 | 23.10 | -0.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.